Literature DB >> 20416467

KITENIN represents a more aggressive phenotype in a murine model of oral cavity squamous carcinoma.

Joon Kyoo Lee1, Sang Chul Lim, Hee Dae Kim, Tae Mi Yoon, Kag Kim, Jong Hee Nam, Hyung Seok Kim, Min-Ho Shin, Kyung Keun Kim.   

Abstract

OBJECTIVE: To investigate the tumor invasiveness and early lung metastasis associated with KITENIN in a murine model of oral cavity squamous carcinoma. STUDY
DESIGN: Cross-sectional study with planned data collection.
SETTING: Department of Otolaryngology-Head and Neck Surgery, Medical Research Center for Gene Regulation, and Pathology, Chonnam National University Medical School and Hwasun Hospital. SUBJECTS AND METHODS: The cDNA of KITENIN and vector only were transfected into the SCC VII (murine squamous cell line) cells. The suspension of 5 x 10(5)/mL viable KITENIN- or vector-transfected SCC VII cells was injected into the floor of the mouth of C3H/HeJ syngeneic mice, deep into the mylohyoid muscle via the intraoral approach. From the first to the sixth week after injection, tumor, lung, liver, and brain tissues were obtained.
RESULTS: For all groups, the tumor invaded the superficial musculature of the floor of the mouth, the deep musculature of the floor of the mouth, the salivary glands, perineural tissue, bone, and skin, sequentially. Lung metastases developed multiple focal nodular patterns at first and then became more extensive. Earlier and more aggressive tumor invasion into the deep floor of the mouth musculature, salivary glands, perineural tissue, bone, and skin was observed in the KITENIN-transfected group compared to the vector-only group. An earlier and more extensive lung metastasis was observed in the KITENIN group.
CONCLUSION: An antisense KITENIN strategy might inhibit distant metastasis and the progression of head and neck squamous cell carcinoma. Copyright 2010 American Academy of Otolaryngology-Head and Neck Surgery Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20416467     DOI: 10.1016/j.otohns.2009.12.032

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  5 in total

1.  KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis.

Authors:  So-Yeon Park; Hangun Kim; Somy Yoon; Jeong A Bae; Seok-Yong Choi; Young Do Jung; Kyung Keun Kim
Journal:  Mol Ther       Date:  2014-06-09       Impact factor: 11.454

2.  Gene therapy for head and neck squamous cell carcinoma using KITENIN (KAI1 COOH-Terminal Interacting Tetraspanin)-antisense therapy.

Authors:  Joon Kyoo Lee; Dong-Hoon Lee; Eun Gene Sun; Jeong A Bae; Sang Chul Lim; Jeong Joon Min; Myung-Whun Sung; Kyung Keun Kim
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

3.  Establishment of a Cell Line (CNUH-HNSCC-1) Derived from an Advanced Laryngeal Squamous Cell Carcinoma.

Authors:  Dong-Hoon Lee; Joon Kyoo Lee
Journal:  Chonnam Med J       Date:  2011-08-31

4.  KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.

Authors:  Kyung-Hwa Lee; Eun-Jung Ahn; Se-Jeong Oh; Ok Kim; Young-Eun Joo; Jeong-A Bae; Somy Yoon; Hyang-Hwa Ryu; Shin Jung; Kyung-Keun Kim; Jae-Hyuk Lee; Kyung-Sub Moon
Journal:  Oncotarget       Date:  2015-02-20

Review 5.  Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma.

Authors:  Zhen-Ge Lei; Xiao-Hua Ren; Sha-Sha Wang; Xin-Hua Liang; Ya-Ling Tang
Journal:  Onco Targets Ther       Date:  2016-01-27       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.